INTRODUCTION
Protein kinase C-d (PKCd) plays a multitude of physiological roles through its ability to phosphorylate multiple target proteins involved in various cellular processes such as signal transduction, 1 apoptosis, 2 proliferation and survival, 3 transcription, 4 hormonal regulation, 5 and immune responses. 6, 7 PKCd À / À mice were originally characterized by two independent research groups who highlighted the role of this kinase in B-cell anergy 8 and B cell-mediated autoimmunity. 9 Furthermore, PKCd À / À mice were protected against glucose intolerance induced by high-fat diet by exhibiting reduced accumulation of liver triacylglycerol and impaired production of lipogenic enzymes. 10 This feature of accumulating fewer lipids during an inflammatory condition by PKCd À / À mice upon Mycobacterium tuberculosis (Mtb) infection might impair its ability to undergo slow-replicating, persistence phase as reported in human sputum. 11 Lipids are a prerequisite for the persistence of Mtb in macrophages that transforms them into foamy macrophages that contribute to tissue pathology and facilitate dissemination. 12 Most studies on the role of PKCd were performed using inhibitors in vitro that lacked in specificity to a particular PKC isoform. A frequently used chemical rottlerin, which is a nonspecific chemical inhibitor of PKCd to block enzymatic reactions and intracellular signaling in pancreatic acinar cells. 13 Rottlerin was shown to reduce viral burdens in human monocyte-derived macrophages during the early stages of HIV-1 infection. 14 Physiologically, silencing of PKCd with anti-PKCd small interfering RNA resulted in increased cholesterol efflux in hamster kidney cells and a murine macrophage cell line RAW264.7. 15 Moreover, PKC isoforms such as d and e are required for phagocytosis in RAW264.7 macrophages, 16 and PKCe also regulates autocrine production of tumor necrosis factor (TNF) that in turn induces apoptosis in lipopolysaccharide-activated macrophages. Studies have suggested a functional role for PKCd in regulating immunity to infectious diseases in vivo. Previously, using PKCd À / À mice, we demonstrated a crucial role of this kinase in macrophage-mediated phagosomal clearance of the intracellular bacterium, Listeria monocytogenes. 7 We further reported that PKCd regulates the production of interleukin-12 (IL-12) p40/70 in both macrophages and dendritic cells, required for protective T helper cell type 1 immune responses in a murine model of cutaneous leishmaniasis. 6 We also demonstrated that deletion of PKCd renders mice susceptible to Candida albicans infection via Card9-mediated antifungal immunity. 18 These studies highlighted the key role of PKCd in the immune response to infectious diseases. However, the functional significance of PKCd in humans and mice along with its effect on lipid homeostasis in host immunity to tuberculosis (TB) infection has not been studied yet.
Here, we report that PKCd mRNA expression is increased in peripheral blood of participants with active TB. In addition, proteomic analysis of lung tissues from treatment-refractory TB patients revealed higher levels of PKCd protein expression in caseous and necrotic regions of cavitory granulomas, highlighting that PKCd might be an indicator of an inflammation. We further demonstrate that deletion of PKCd in mice has a detrimental effect on a host with increased bacterial loads, enhanced lung pathology, and mortality. Moreover, PKCd is critical for the accumulation of lipid bodies in macrophages and lungs during Mtb infection. Mechanistically, PKCd is important for optimal macrophage killing effector functions, independent of phagosome maturation and autophagy.
RESULTS

Increased expression of PKCd during active TB disease
Recently, we identified a transcriptomic signature that has the potential to distinguish latent infection from the development of active disease. 19 Given the pivotal role of PKCd in signal transduction, we asked whether expression of this kinase changes during the transition from Mtb infection to TB disease. We analyzed gene expression data in whole blood from a nested control study correlating risk of TB from 800 days before diagnosis. This included 46 adolescents with latent Mtb infection who progressed to active disease (progressors) and 107 adolescents with Mtb infection who remained healthy. 19 PKCd was significantly upregulated in progressors when compared with latently infected healthy controls ( Figure 1a) . Although two PKC isoforms (y and Z) exhibited downregulation during progression to active TB disease, the expression levels of other PKC isoforms (a, b, g, i, e, and z) remained constant (Supplementary Figure S1 online ). This highlighted PKCd as a possible marker of active TB disease that we sought to validate using quantitative real time-PCR (qRT-PCR). PKCd mRNA expression was significantly higher in whole blood from 8 participants with pulmonary TB disease when compared with 16 QFT À healthy controls (QFT À ) but not with latent Mtb infection (QFT þ ) (Figure 1b) .
However, the latter was also significantly higher in whole blood of a larger independent Strategic Health Innovation Partnerships (SHIP) cohort of 30 active TB participants and 30 healthy individuals (QFT þ ) with latent Mtb infection ( Figure 1c ). In addition, human monocyte-derived macrophages (MDMs) also upregulated PKCd expression following Mtb infection (Figure 1d) . Collectively, these data indicate that PKCd expression increases during active TB disease and in vitro Mtb infection of macrophages.
We then explored whether anti-TB therapy would decrease PKCd expression. We analyzed a publicly available data set from an independent study 20 that reported whole-blood expression profiles of 27 first-time TB patients before and after treatment. We found that PKCd was the most abundantly expressed isoform compared with other PKC isoforms. Importantly, the expression decreased from week 1 to 26 weeks of successful treatment with TB therapy (Figure 1e) . Of note, all other PKC isoforms remained unchanged before and after TB therapy except PKCy that was marginally increased only at completion of treatment ( Figure 1e ). This decline in PKCd expression after treatment suggests that it might be an important component or mediator of the host immune response during active TB disease.
PKCd is highly expressed in necrotic and cavitary regions of granulomas in patients with multidrug-resistant TB
We recently characterized proteomic signatures in various regions of granulomas from treatment-refractory TB patients who had undergone pneumonectomy due to severe lung damage. 21 Using the proteomics data, we determined the protein expression levels of various PKC isoforms. Our analysis revealed that only PKCd was associated with the necrotic regions of both caseous and cavitary granulomas (Figure 1f) , whereas other PKC isoforms were largely absent in the lung tissue samples (data not shown). This suggests an association of PKCd within the regions of Mtb-specific host immune responses at the site of disease. The abundance of PKCd protein at the sites of exaggerated disease strengthens our transcriptomic findings in whole blood, highlighting PKCd as a host factor that is induced during the progression of cellular to necrotic granulomas in humans.
PKCd is critical for host survival against Mtb infection in mice
To further investigate how PKCd influences host mortality during Mtb-infection, we compared PKCd À / À mice 6,7 with wild-type controls in a murine model of experimental TB. Deletion of PKCd rendered mice highly susceptible to various doses of intranasal Mtb infection (Figure 2a,d,g ). Earlier and increased mortality was associated with rapid weight loss (Figure 2b ,e,h) and increased bacterial titers in the lungs and spleen determined at the time of killing (Figure 2c,f,i) . Thus, PKCd deficiency in mice results in increased bacterial burdens and mortality during Mtb infection. As PKCd mice succumbed to Mtb infection as early as 4 weeks in mortality studies (Figure 2d) , we performed an in-depth analysis of disease parameters at 4 and 8 weeks using a dose of 1,000 colony-forming units (CFU). At 4 and 8 weeks after infection, PKCd À / À mice displayed higher lung and spleen burdens (Figure 3a) , corroborating the mortality findings. Susceptibility to infection in PKCd À / À mice was further accompanied by a significant increase in lung inflammation as revealed by lung weight index (Figure 3b ), higher pulmonary cell recruitment (Figure 3c) , and larger lesion area in hematoxylin and eosin-stained lung sections at 4 and 8 weeks after infection (Figure 3d) . Furthermore, immunohistochemistry revealed that inducible nitric oxide synthase (iNOS) production was significantly increased in the lungs of PKCd À / À mice, concomitant with increased pulmonary tissue pathology indicating that PKCd might directly or indirectly contribute to the control of lung pathology (Figure 3e ). Given the importance of PKCd in the accumulation of cholesterol in human monocyte-derived macrophages, 22 we investigated lipid accumulation in the lungs of PKCd À / À mice. Oil Red O staining of lung tissue sections of PKCd À / À mice displayed significantly reduced accumulation of lipids in lungs when compared with wild-type animals after 4 and 8 weeks of infection (Figure 3f) . We next assessed whether inhibiting PKCd in wild-type mice using a specific peptide inhibitor TatVd1.1 (ref. 23 ) would recapitulate exaggerated lung pathology of PKCd À / À mice following Mtb infection. Indeed, mice treated with TatVd1.1 had significantly higher lung weight index and more inflamed lung sections and lesion size when compared with wild-type animals (Supplementary Figure S2a-c) . Together, these results demonstrate that absence of PKCd in Mtb infection resulted in exacerbated pathology and reduced accumulation of lipids in the lungs. 
Decreased lipid accumulation in lungs of PKCd
À / À mice during Mtb infection prompted us to perform a total metabolome extraction of the serum in these animals. Principal component analysis showed a clear differentiation between Mtb-infected (1,000 CFUs) wild-type and PKCd À / À mice at week 4 (62% variance) and week 8 (64% variance) after infection, respectively (Figure 5a,b) . Metabolite profiles of these two groups thus varied significantly to allow a natural grouping of the individual samples. Fatty acids are determined to be of significance via univariate and multivariate statistical analysis presented in Tables 1 and 2 . Considering these results, Mtb-infected PKCd À / À mice showed significantly decreased levels of all serum fatty acids when compared with wild-type mice, except for mead acid, an elevation of which is a wellknown marker for fatty acid deficiencies. 24 Here, we selectively report that host-protective (arachidonic acid, a-linoleic acid, and palmitic acid) 25 and host-detrimental (behenic acid, cervonic acid/docosahexaenoic acid, and timnodonic acid/ eicosapentaenoic acid) 25 fatty acids were significantly lower in the PKCd À / À mice during Mtb infection (Figure 5c ,d). To assess whether the observed effect was indeed PKCd specific and not a consequence of morbidity and pathology at this dose resulted in reduced food/water intake, we performed metabolomics at a low dose (70 CFUs) and found similar results (Supplementary Figure S5a -d) as with 1,000 CFUs ( Figure 5) . Notably, we confirmed that the changes in lipid profiles were not a function of bacterial loads in the lungs of wild-type mice (Supplementary Figure S5e) . Thus, the absence of PKCd led to a marginal decrease in serum fatty acids of Mtb-infected mice.
Macrophages deficient in PKCd exhibit reduced mycobacterial killing capacity and reduced accumulation of lipid bodies Using our publically available data set from CAGE sequencing of macrophages infected with a hypervirulent Mtb strain (HN878), 26 we reported that PKCd in the murine bone marrow-derived macrophages (BMDMs) was also upregulated, whereas other PKC isoforms (except b) remained largely unaffected (Figure 6a) , PKCd expression was also validated by qRT-PCR in murine macrophages (Supplementary Figure S4a) . Given the entire study was performed with an H37Rv strain of Mtb, we measured the expression of PKCd in H37Rv-infected macrophages ( Figure 6b ) that had slightly different kinetics at 24 h after infection when compared with HN878-infected macrophages ( Figure 6a and Supplementary Figure S4a ). This discrepancy in expression kinetics at 24 h was most likely due to the different strains of Mtb. We next investigated the intracellular growth of Mtb in PKCd À / À macrophages. Mycobacterial growth was significantly increased in PKCd À / À macrophages particularly at 3 and 6 days after infection (Figure 6c ) as well as in wild-type macrophages transfected with anti-PKCd small interfering RNA at 48 h after infection (Supplementary Figure S4b) .
In PKCd
À / À mice, we found a reduced accumulation of the lipid bodies in the Mtb-infected lungs. Similarly, PKCd À / À macrophages displayed fewer lipid bodies revealed by the Oil Red O staining (red) in fluorescent microscopy in a time-dependent manner concomitant with significantly higher bacterial numbers (Rv-GFP, green) (Figure 6d,e) . Unlike in the in vivo model, we found no differences in cytokine production by PKCd À / À BMDMs except for a significant decrease in IL-6 (Figure 6f-i) , suggesting other cell populations contributed in the lungs. Thus, PKCd is important for macrophage-mediated containment of mycobacteria and lipid accumulation.
Killing effector functions in
The PKC isoforms, including b 27 and a, 28 were reported to be important for maturation of Mtb-containing phagosomes. In bacterial infection, we previously reported that PKCd is critical for containment of L. monocytogenes in phagosomes of macrophages.
7 Surprisingly in Mtb infection, no differences in the analyzed phagosome markers including LAMP-1, LAMP-3, Cathepsin-D, and an autophagy marker LC3-II were observed between PKCd À / À and control macrophages (Figure 7a,b) . This result suggests that PKCd is dispensable for phagosome and autophagy-mediated killing of Mtb in macrophages.
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Data are represented as mean ± s.e.m. of n ¼ 4-5 mice/group and are representative of two independent experiments. Data are analyzed using unpaired Student's t-test, *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001, vs. wild-type (WT) control mice. Act, activated; Alv, alveolar; Mph, macrophage.
As the intracellular killing of Mtb is enhanced by nitrogen and oxygen species, 29 we measured the ability of isolated macrophages to release reactive oxygen species (ROS), hydrogen peroxide (H 2 O 2 ), and nitric oxide (NO). We found NO production was significantly decreased in PKCd À / À macrophages at the protein level ( Figure 7c ) and mRNA level using qRT-PCR (Figure 7d) . In addition to NO, the release of H 2 O 2 ( Figure 7e ) and ROS ( Figure 7f ) was also significantly decreased in the PKCd À / À macrophages. Furthermore, the absence of PKCd in macrophages during Mtb infection also renders them more prone to apoptosis, revealed by Annexin V and 7-aminoactinomycin D staining (Figure 7g) . Moreover, we also evaluated the possible effect of antimicrobial molecules secreted into the cell supernatant by Mtb-infected macrophages by incubating infected PKCd À / À cells with supernatants from wild-type cells, and vice versa. Supernatant from infected wild-type macrophages indeed reduced bacterial growth in (Figure 7h) . This indicates that a deficiency of PKCd decreases optimal oxidative and nitrosative killing effector functions in macrophages thereby favor bacterial growth. (Figure 7i ). On the other hand, wild-type macrophages in the presence of Ox-LDLs showed a significant increase in bacterial growth when compared with untreated wild-type cells (Figure 7i ). In addition, Ox-LDLs increased lipid accumulation in wild-type macrophages but not in PKCd À / À macrophages (Supplementary Figure S4e) .
Moreover, we evaluated the effect of an unsaturated (oleic acid), saturated (palmitic acid) fatty acids, and native-LDLs on PKCd À / À macrophages. In contrast to Ox-LDLs, we found a significant increase in growth of Mtb in PKCd Figure S4c) with a concomitant decrease in production of NO (Supplementary Figure S4d) in the presence of oleic acid and native-LDLs. Interestingly, macrophages treated with palmitic acid had no effect on Mtb growth (Supplementary Figure S4c) . Furthermore, macrophages treated with oleic acid, palmitic acid, and native-LDLs had no major effect on lipid accumulation (Supplementary Figure S4e) . Collectively, these findings suggest that fatty acids have a differential effect on the PKCd signaling during mycobacterial growth in vitro and might not be a major contributing factor for increased mycobacterial burdens observed in vivo.
macrophages (Supplementary
DISCUSSION
We have demonstrated the functional role of PKCd in host defense against Mtb infection in humans and mice. PKCd is highly expressed in human whole blood during active TB disease progression as well as within the Mtb-specific proinflammatory regions of necrotic and cavitary lung granulomas during TB disease. These regions of high proinflammatory signatures are required for an early control of bacterial replication and could lead to necrotic damage (caseation) and consequent cavity formation if not appropriately regulated. 30 Evidently, PKCd was more abundant in the caseous and cavitary regions in this study, colocalizing with antimicrobial signatures 21 and the regions of abundant lipids in granulomas. 31 However, it is not clear whether mediators of inflammation and antimicrobials are responsible for the overwhelming inflammation at the site of infection, or they are remnants of a robust immune response meant to eliminate À / À and wild-type (WT) BMDMs were infected with green fluorescent protein (GFP)-expressing Mtb (green, H37Rv) and stained with Oil Red O (red) for visualization and determination of intracellular bacteria and quantification of lipid bodies (inset is bright-field view). (f-i) Cell-free supernatants from infected macrophages were analyzed for the production of tumor necrosis factor (TNF), interleukin (IL)-12p40, IL-6, and IL-1b at indicated time points after infection by enzyme-linked immunosorbent assay (ELISA). Data are represented as mean±s.e.m. of quadruplicate and representative of three independent experiments. Data are analyzed using unpaired Student's t-test, *Po0.05, **Po0.01, ***Po0.001, vs. WT control macrophages.
the pathogen in the lung. Consistently, we found PKCd as an indicator of lung inflammation in yet another whole-blood transcriptome data set from pulmonary infections such as sarcoidosis, TB, pneumonia, and lung cancer. 32 Given the nonspecificity to TB and substantial overlap in PKCd expression between our cohorts, this kinase offers a limitation to be used as a prognostic marker. Distinctly using mass spectrometry, we showed that the expression of PKCd varies within the regions of lung granuloma. Notably, anti-TB therapy decreased PKCd expression in whole blood of human patients, reflecting a potential role for this protein kinase as a host factor regulating Mtb-driven inflammation.
Our findings revealed that PKCd is indeed associated with host defense against murine TB as PKCd ablation enhanced À / À mice were pretreated with or without oxidized low-density lipoproteins (Ox-LDLs) overnight. Cells were then infected with Mtb-containing medium with or without Ox-LDLs for 3 days to determine mycobacterial growth. Data are represented as mean ± s.e.m. of quadruplicate and are representative of three independent experiments. Data are analyzed using unpaired Student's t-test, *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001, vs. WT control macrophages. mortality with rapid weight loss, high bacterial loads, and exacerbated lung pathology. In these mice, we found higher levels of lung proinflammatory cytokines during Mtb infection, consistent with our published reports on the role of PKCd in listeriosis 7 and cutaneous leishmaniasis. 6 Remarkably, inhibition of PKCd using a specific peptide inhibitor TatVd1.1 (ref. 23 ) recapitulated aggravated lung inflammation in PKCd À / À mice during Mtb infection, revealing a direct role of this kinase in regulation of lung inflammation.
Alveolar macrophages (AMs) are essential for protection during Mtb infection in mice, 33 and we found strikingly reduced numbers of AMs with concomitantly higher lung bacterial loads that could lead to necrosis in PKCd À / À mice. To control enhanced bacterial burdens, activated macrophages and monocytes are recruited that perhaps explain excessive NO oxide in the PKCd À / À lungs, in contrast to PKCd À / À macrophages in vitro. Notably, mice deficient in AMs due to the deletion of granulocyte-macrophage colony-stimulating factor develop a disorder of accumulated surfactant lipids in the alveolar spaces of the lungs. 34 Despite reduced AMs in PKCd À / À mice, we did not observe increased lipid staining in the lungs. This could be due to the increased recruitment of activated macrophages that catabolize surfactant lipids along with type II alveolar epithelial cells. 35 Importantly, it is feasible that due to higher bacterial burden AMs decreased in PKCd À / À mice. Consequently, increased inflammatory cell recruitment to the lungs as a result of proinflammatory cytokines, which in turn might have decreased alveolar spaces (for gas exchange), translated in the mortality in these mice during Mtb infection. Our findings suggest that PKCd is required for maintenance of an optimal inflammatory balance during Mtb infection that is a key factor in limiting immunopathology to host lung tissue. We infer from these findings where PKCd ablation in mice renders them hypersusceptible to TB, and therefore it is likely that increased expression (blood) and abundance (granulomas) of this kinase reflect its role as a host factor to contain ongoing inflammation in humans.
Host lipid bodies provide an excellent nutrient source for the survival of intracellular Mtb, 36 thereby decreasing its own metabolism 37 that allows pathogenesis 38 and persistence 12, 39, 40 of the bacterium. The necessity of triacylglycerol for slow replication was demonstrated in a recent study where deposition of excessive triacylglycerol in Mtb bacterium slowed down its growth as opposed to a Mtb strain capable of pumping out lipids. 41 Reports have indicated a critical role of PKCd in the accumulation of cholesterol in human 22 and mouse 15 macrophages and triacylglycerol during glucose intolerance induced by high-fat diet in PKCd À / À mice. 10 Corroborating with these findings, we found that PKCd is indeed critical for the accumulation of lipids in the lungs, macrophages, and to a lesser extent in the case of serum fatty acids following Mtb infection. The latter may not contribute much to the biological relevance owing to subtle differences. Notably, it has been shown that in steady state, absence of PKCd is dispensable for the uptake of Ox-LDL to induce foam cell formation in murine and human macrophages. 42 Moreover, our observations of Mtb loads in PKCd À / À macrophages pretreated with unsaturated, saturated fatty acids, and oxidized and native LDLs supported that lipid accumulation might not necessarily contribute to the intracellular bacterial growth in macrophages deficient for PKCd. Recently, it was shown that increased lipids in lungs and macrophages drive the polarization of macrophages (M2) involved in fibrosis. 43 In PKCd À / À mice, the decreased availability of lipids and enhanced proinflammatory cytokines might have limited tissue repair processes in the lungs. Thus, lipid accumulation can be the consequence rather than the cause of susceptibility to Mtb infection in PKCd À / À mice. This Mtb-driven modulation of host lipids may be the means by which this highly evolved pathogen controls its replication rate in vivo. It is feasible that inability of PKCd À / À mice to accumulate intracellular lipids hampers the ability of Mtb to undergo slow-replicative state during infection.
Intracellular Mtb can be eliminated by the induction of macrophage phagosome maturation 44 and autophagy. 45 The PKC isoforms, including b 27 and a, 28 were reported to be important for maturation of Mtb-containing phagosomes. In contrast to PKCb and PKCa, our findings indicated that PKCd is dispensable for phagosome maturation and autophagy in Mtb-infected macrophages. An alternative explanation is that PKCd, unlike other isoforms (a, b, and g), is insensitive to calcium signaling 46 that is important for phagosome maturation. Another isoform PKCz has been implicated as a key factor for TLR2-ERK1/2 (Toll-like receptor 2/extracellular signalregulated kinase 1/2)-mediated secretion of TNF in both murine and human macrophages following Mtb infection in vitro. 47 However, inhibition of PKCd with rottlerin abrogated apoptosis in murine macrophages when cultured with cell-free supernatant of Mycobacterium indicus pranni (Mw). 48 In contrast, we observed increased apoptosis in PKCd À / À macrophages following Mtb infection. This observation strengthens accumulating evidence regarding the nonspecific actions of rottlerin as a PKCd inhibitor. 13, 42 As we found no effect on phagosome maturation and autophagy, we probed other effector functions in which PKCd might be involved. It is well established that within macrophages, Mtb can be successfully eradicated by oxidative (ROS, H 2 O 2 ) and nitrosative (NO) killing functions. 29 Interestingly, IFN-g-activated macrophages synergistically increase NO production by fivefold upon phorbol 12-myristate 13-acetate-mediated PKC activation in Mycobacterium bovis (Bacillus Calmette-Guérin (BCG))-infected macrophages. 49 Indeed, this was confirmed in our study as the presence of PKCd enhanced killing effector functions, whereas the absence thereof inhibited these effector responses, thereby reducing the mycobacterial killing capacity of PKCd À / À macrophages. To our knowledge, there has been no report on a functional role for PKCd in immunity to TB in mice and humans.
Collectively, our data revealed that PKCd is an indicator of inflammation in both systemic and local tissue compartments during active TB disease progression in humans. Global deletion of PKCd worsens the Mtb disease outcome in mice that exaggerated mortality with a shift toward increased bacterial burdens, exacerbated pathology, and excessive proinflammatory responses. To a lesser extent following Mtb infection, decreased lipids in lungs and macrophages of PKCd À / À mice might further reduce the possibility for this bacterium to undergo persistence. Mechanistically, reduced killing effector functions in macrophages increased susceptibility to Mtb in the absence of PKCd. Taken together, the onset of active human Mtb disease correlates with PKCd expression, and conferring from our murine model, PKCd might be a critical factor employed by the host to control exacerbation of Mtb infection.
METHODS
Whole-blood mRNA signature of PKC. For whole-blood transcriptomics, we analyzed the publicly available RNA-sequencing data set from the Adolescent Cohort Study. 19 We determined expression profiles of all PKC isoforms from 800 days before diagnosis of TB disease. A detailed description of the study and analysis is mentioned in Supplementary Methods. Human PKCd expression following treatment and lung proteomics from treatment-refractory TB patients. The blood gene signature from the publically available data set in the NCBI-GEO (National Center for Biotechnology Information Gene Expression Omnibus) database, accession number GSE31348, was used to analyze PKC expression of all isoforms during TB treatment. 20 For human lung proteomics, we analyzed the available data that have been deposited into the PRIDE partner repository with the data set identifier PXD003646. The heat map plot was constructed by calculating z-scores of PKCd abundance in different types of granulomas derived from multidrug-resistant TB patients. Details of the patients and surgical procedures have been described previously. 21 Mice. PKCd-deficient (PKCd À / À ) mice on the 129Sv genetic background (8-12 weeks) were maintained under specific pathogenfree conditions in individually ventilated cages. All experiments were performed in accordance with the South African National Guidelines and University of Cape Town practice for laboratory animal procedures. The protocol (AEC: 012/036) was approved by the Animal Ethics Committee, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Mtb infection and determination of bacterial loads in mice. Mtb (H37Rv) was grown to log phase in 7H9 complete media, and stocks were prepared for infections via an intranasal route as described previously. 50 Bacterial loads in lungs and spleen of Mtb-infected mice were determined at indicated time points after infection. Briefly, organs from killed mice were removed aseptically, weighed, and homogenized in 0.04% Tween-80. Tenfold dilutions were plated onto Middlebrook 7H10 (BD Biosciences, San Jose, CA) agar plates supplemented with 10% OADC and 0.5% glycerol and incubated at 37 1C for 21 days before colonies were counted.
Histopathology, immunohistochemistry, and lipid staining of the lungs. Formalin-fixed (10%) lung tissue from Mtb-infected mice was cut into 3 mm sections and stained with hematoxylin and eosin for histopathological analysis. For iNOS staining, immunohistochemistry was performed using rabbit anti-mouse iNOS (Abcam, Cambridge, UK) as described previously. 51 Neutral lipids were analyzed in lung sections of Mtb-infected mice or macrophages by Oil Red O (SigmaAldrich, St. Louis, MO) staining for 5 min following washing and then a rinse with 60% isopropanol. 52 Sections were mounted using the gelatine-based mounting medium. Image acquisition and quantification of lesion area, iNOS staining, and area covered by lipid bodies were performed on a Nikon (Tokyo, Japan) 90i microscope using NIS advanced software.
Cytokine responses and immune cell populations in lungs using fluorescence-activated cell sorting. Supernatants from lung homogenates were collected for the determination of cytokines. IFN-g, TNF, IL-6, IL-10 (all from BD Biosciences, San Jose, CA), IL-1b (R&D Systems, Minneapolis, MN), and IFN-b (Biolegend, San Diego, CA) productions were quantified in these supernatants by enzyme-linked immunosorbent assay. Single-cell suspension of Mtb-infected lungs was prepared following collagenase digestion as previously described. 51 Cells were then stained for lymphocytes (CD4 þ , CD8 þ T cells and B cells) and myeloid populations (alveolar macrophages, activated macrophages, dendritic cells, and neutrophils). Surface phenotyping of various cell populations was performed using the following antibodies: CD3-FITC, CD4-PE, CD8-APC, CD19-PerCP, CD11c-APC, CD11b-PE, MHCII-FITC, Siglec-F-PE, and Gr-1-FITC (all from BD Biosciences). Cells were acquired on a FACS Calibur and the data were analyzed using FlowJo software (v10.1, Tree Star, Ashland, OR) as described previously. 51 Metabolome analysis in serum of PKCd mice using gas chromatography-mass spectrometry. Extraction of the collected serum samples from Mtb-infected PKCd À / À and wild-type mice at 4 and 8 weeks after infection was performed as previously described 53 using 50 ml of 0.45 mg ml À 1 3-phenylbutyric acid (Sigma-Aldrich) as an internal standard before gas chromatography by gas chromatography with time-of-flight mass spectrometry (GC Â GC-TOFMS) analyses. A detailed description is included in Supplementary Methods.
Mtb infection in vitro. Murine BMDMs and human MDMs were generated as previously described. 50 Macrophages were pretreated with either Ox-LDLs (100 mg ml À 1 ), native-LDLs (125 mg ml À 1 ), oleic acid (500 mM), palmitic acid (500 mM), or left untreated overnight. Cells were then infected in the presence of treatment(s) with Mtb (H37Rv, unless otherwise indicated) with multiplicity of infection of 2. At indicated time points, cells were lysed in 0.1% Triton X-100 for determination of bacterial growth or fixed using 4% paraformaldehyde for visualization of bacteria and Oil Red O staining. Images were acquired using a Carl Zeiss 510 (Jena, Germany) confocal microscope and bright-field images were analyzed for the area under the lipid stain as mentioned above. Western blot analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blot analysis was performed as previously described. 50 Briefly, macrophages (3 Â 10 6 ) were infected with Mtb at multiplicity of infection of 2 for 4 h. Cells were washed and then lysed with ice-cold RIPA buffer containing protease inhibitors for 30 min at 4 1C. Total cell lysates were analyzed for protein contents using BCA assay (ThermoFisher, Waltham, MA). An equal amount of protein (40 mg) was then electrophoresed on 12% sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Sigma). The membrane was probed with anti-LAMP-1, LAMP-3, Cathepsin-D, LC3-II, and GAPDH primary antibodies diluted (1:200) in blocking buffer at 4 1C overnight. The membrane was then incubated with the horseradish peroxidase-conjugated secondary antibody (1:10,000) for 1 h at room temperature in blocking buffer. Immunoblots were developed using Super Signal West Dura substrate (Pierce, Waltham, MA). Cell supernatants from infected macrophages were collected for measurement of NO using Griess reagent. H 2 O 2 release from macrophages was measured using colorimetric detection kit (Amplex Red Hydrogen Peroxide Assay, ThermoFisher). ROS was determined in macrophages using nitroblue tetrazolium (NBT, Sigma-Aldrich) that is reduced to a dark-blue insoluble formazan. Cells were incubated for phosphate-buffered saline containing 0.2% NBT for 90 min. Formazan was dissolved in 0.04% HCL in isopropanol, and the absorbance was determined at 560 nm. 54 Quantification of Oil Red O staining in macrophages was determined following solubilizing of lipid droplets in isopropanol and the absorbance was determined at 490 nm. 55 Statistics. All data were analyzed using GraphPad Prism v 6.0 (GraphPad, La Jolla, CA) and Student's t-test (two-tailed with unequal variance) unless otherwise stated. A P value of 0.05 was considered significant. Statistics regarding RNA-sequencing data analysis is included in Supplementary Methods.
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